SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI by Lambert, Madeleine
SIT Graduate Institute/SIT Study Abroad
SIT Digital Collections
Independent Study Project (ISP) Collection SIT Study Abroad
Fall 2018
SILENT KILLERS: DIABETES AND THE
ACTIVE IGNORANCE OF
NONCOMMUNICABLE DISEASE IN BALI
Madeleine Lambert
SIT Study Abroad
Follow this and additional works at: https://digitalcollections.sit.edu/isp_collection
Part of the Food Studies Commons, International and Community Nutrition Commons, and the
South and Southeast Asian Languages and Societies Commons
This Unpublished Paper is brought to you for free and open access by the SIT Study Abroad at SIT Digital Collections. It has been accepted for
inclusion in Independent Study Project (ISP) Collection by an authorized administrator of SIT Digital Collections. For more information, please
contact digitalcollections@sit.edu.
Recommended Citation
Lambert, Madeleine, "SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE











SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF 








Project Advisor: Dr I Made Januarbawa 
SIT Study Abroad  
Indonesia: Arts, Religion, and Social Change  
Fall 2018 
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 2 
Table of Contents 
Acknowledgements ................................................................................................................ 4 
Abstract ................................................................................................................................. 6 
Introduction .......................................................................................................................... 7 
Research Questions and Objectives ..............................................................................................8 
Field Methods and Ethics..............................................................................................................9 
List of terms ................................................................................................................................ 12 
Limitations ................................................................................................................................. 12 
Background......................................................................................................................... 14 
Literature Review ....................................................................................................................... 14 
Interviews in Tabanan ................................................................................................................ 16 
Overview of Diabetes in Bali ................................................................................................ 18 
Diagnosis .................................................................................................................................... 18 
Treatment ................................................................................................................................... 19 
BPJS ................................................................................................................................................................... 20 
Non-BPJS ........................................................................................................................................................... 21 
Outcomes .................................................................................................................................... 22 
Case Studies from Kayubihi ................................................................................................. 25 
Pak Wayan Karem ..................................................................................................................... 25 
Pak Nyoman Kuat ...................................................................................................................... 26 
Analysis .............................................................................................................................. 29 
Resistance to Seeking Medical Care ............................................................................................ 29 
Misunderstandings about Chronic Disease ................................................................................. 30 
Regional Differences ................................................................................................................... 31 
BPJS ........................................................................................................................................... 33 
Focus on Primary Care ...................................................................................................................................... 33 
Resistance to Use ................................................................................................................................................ 33 
Confusion over Usage ........................................................................................................................................ 34 
Trends in Diabetes Diagnosis and Management .......................................................................... 34 
Increasingly Earlier Diagnosis .......................................................................................................................... 34 
Increasing Adherence to Medication and Lifestyle Changes ............................................................................. 35 
Increasing Insulin ............................................................................................................................................... 35 
Conclusion .......................................................................................................................... 36 
Suggestions for Further Research ........................................................................................ 38 
Regionally Specific Data ............................................................................................................. 38 
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 3 
Health Equity ............................................................................................................................. 38 
Other Noncommunicable Diseases .............................................................................................. 38 
Balian in Present-Day Healthcare ............................................................................................... 39 
References........................................................................................................................... 42 
Primary Sources ......................................................................................................................... 42 
Secondary Sources ...................................................................................................................... 42 
 
  
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 4 
Acknowledgements 
 First and foremost, I have to thank my advisor Dr. Jon for his constant guidance and 
support. Dr. Jon, you have been absolutely invaluable to my independent study project. I had 
never conducted my own field research before, and your connections in the field and your 
invariable responsiveness to my questions, no matter how vague or nitpicky, saved me from a lot 
of frustration. For that, and for the many small acts of kindness you have shown me along the 
way, thank you for making my ISP a thoroughly exciting experience. 
 Second, a huge thank you to all the informants who let me into their busy lives for an 
hour or so and made writing my ISP enjoyable. To all the healthcare providers and the patients, 
Pak Nyoman and Pak Wayan, you have taught me so much more about diabetes in Bali than any 
medical publication. Specifically, I want to thank Pak Romi and his family, who let me into their 
lives for a little over an hour and allowed me to tag along to their village of Kayubihi for a day to 
interview Pak Romi’s patients. Pak Romi, your experience in your field and your generosity truly 
helped shape my ISP. I had so much fun talking and laughing with your daughter, and I will 
never forget the kindness (or the delicious food!) your wife and mother showed me over dinner. I 
want to thank you, your family, and your village for your hospitality. 
 Third, I have to thank the staff of SIT Indonesia: Arts, Religion, and Social Change for 
their support in preparing us for the challenges of the ISP period. Bu Ary, you are like a second 
mother to us. Your good humor, experience, patience, and your extreme compassion have made 
my time in Indonesia unforgettable. I cannot thank you enough for giving me such a highlight in 
my life. To Pak Yudi, you have been a mentor and a friend to me. Thank you for your openness 
and for your willingness to have long discussions with me before I had even fully formed an idea 
for my ISP; your feedback more than anything prepared me to start my project. To Sani, Dian, 
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 5 
and Kazu, thank you for your support and responsiveness throughout our time in Indonesia. You 
have been excellent teachers and excellent company. 
 Finally, to my homestay family in Kerambitan: you have been so much more than a place 
to eat and sleep. Especially to my Ibu and my sister Sinta, you have so thoroughly and 
generously invited me into your lives. You have given me comfort and compassion in an entirely 
new environment for me. I have felt more welcome here than I ever thought possible, and truly 
think of you as family. I can only hope I ever get the chance to repay you for your hospitality and 
love. Thank you for giving me a second home on the other side of the world. 
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 6 
Abstract 
 In this paper, I will explore the growing burden of non-communicable diseases and 
specifically diabetes in Bali. I will study the general publics’ awareness and behaviors about 
noncommunicable diseases, as well as the attitudes and behaviors of diabetic patients towards 
their own condition. Furthermore, I will explore the diagnosis, treatment, and outcomes of 
diabetes, as well as the impact of the Indonesian national healthcare reform of 2014 on these 
issues. My objectives in this study were to explore the perspectives of both patients and 
healthcare providers towards diabetes, and to compare and contrast these perspectives both 
against each other and against the assumptions I had made from my literature review going into 
the field. I found that they often challenged each other.  
More than anything, I found that healthcare in Bali is in a massive state of transition, 
from the introduction of the single state healthcare provider and increasing awareness about 
noncommunicable disease. Conflicting accounts from healthcare providers on the diagnosis, 
treatment, and outcomes for diabetes reflect both regional differences and the changes that have 
already begun in Balinese health. While old mindsets about resistance to seeking medical care 
and misunderstandings about the nature of chronic disease persist, even strongly in more rural 
regencies, providers are reporting increasingly earlier diagnosis, better adherence to medication, 
and fewer complications in patients with diabetes. 
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Introduction 
Lower middle-income countries, especially in Southeast Asia, have experienced a rise in 
noncommunicable disease (NCD) burden in recent decades as populations adapt to more 
“modern” lifestyles. In Indonesia, NCDs represented 43% of the country’s disease burden in 
1990 (Fountaine, Lembong, Nair, & Süssmuth-Dyckerhoff, 2016). As of 2016, that percent had 
increased to 69%, a number that continues to rise. The growth in NCDs is both deadly and 
expensive. Three NCDs – cardiovascular disease, diabetes, and respiratory diseases – accounted 
for 50% of all deaths in Indonesia in 2014. The costs associated with these same NCDs will cost 
the country 2.8 trillion USD from 2012 to 2030 (Fountaine, Lembong, Nair, & Süssmuth-
Dyckerhoff, 2016). 
The annual rise of type 2 diabetes in particular caught my interest. As a pre-medical 
student studying Global Health, as well as a member of a Southeast Asian family with a history 
of diabetes myself, I noticed immediately in country that many aspects of modern Balinese 
lifestyle – including but not limited to the high smoking rates in men, the frequent consumption 
of sugar-sweetened beverages and the carbohydrate-rich diet, and the reduction in physical 
activity in favor of motorbikes – are risk factors for type 2 diabetes. In my preliminary research, 
I found that Indonesia represents the fifth largest population of diabetics in the world, with the 
disease affecting 6-7% of Indonesians (Snouffer, 2017). That population is expected to rise from 
9 million in 2014 to 14 million by 2035. Most alarmingly, I found that 70% of cases go 
undiagnosed (Soewondo, Ferrario, & Tahapary, 2013). When patients are diagnosed, it most 
often occurs late in the disease pathway, with patients waiting for two or more complications to 
develop before seeking care. Furthermore, once diagnosed, only 30-35% of patients are hitting 
recommended treatment targets in Indonesia (Fountaine, Lembong, Nair, & Süssmuth-
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Dyckerhoff, 2016). Patients frequently do not follow-up properly with their healthcare providers, 
and adherence to medication and lifestyle changes is inconsistent. 
These issues are inseparable from the Indonesian healthcare system as a whole and 
specifically with access to primary healthcare, which can detect health issues before they become 
major complications and severely reduce the costs and life years lost associated with diabetes. To 
address these issues, along with growing health inequity, Indonesia launched a massive 
healthcare scheme called Jaminan Kesehatan Nasional (JKN, the National Health Insurance) in 
2014 to achieve universal health coverage by 2019. This reform launched the Badan 
Penyelenggara Jaminan Sosial (BPJS, or the Social Insurance Administration Body), one of the 
largest state single healthcare providers in the world with 195 million people enrolled in the 
program as of April 2018 (“The Financial Sustainability,” 2018). Regardless, more than one third 
of the country remains without health coverage of any kind. Even among BPJS members, out-of-
pocket spending remains common (Wiseman et al., 2018). 
Research Questions and Objectives 
As a student of both medicine and health systems, I came out of my preliminary research 
with questions about the perspectives of the patient, the healthcare provider, and the healthcare 
system as a whole. To guide my study, I composed a set of research questions as follows: 
1. Why do Indonesians wait so long before seeking care in the case of serious symptoms?  
2. What treatment choices are available for diabetics?  
3. How are self-care behaviors, among the most common treatments for type 2 diabetes, 
prescribed and implemented?  
4. How has BPJS changed the diagnosis and treatment outcomes for type 2 diabetes?  
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5. How is the landscape of healthcare shifting to primary care to accommodate the growing 
burden of noncommunicable diseases, if at all? 
My objectives in this study were to explore the perspectives of the public, diabetic 
patients, and healthcare providers towards diabetes, and to compare and contrast these 
perspectives against each other and against the assumptions I made going into the field. I 
specifically focused on the diagnosis, treatment, and outcomes of the disease. Furthermore, I 
wanted to view these perspectives against the backdrop of a drastically changing healthcare 
landscape and to see firsthand the impact of BPJS on diabetics’ everyday lives. 
Field Methods and Ethics 
 I was based in Denpasar for the majority of the ISP period. As the capital of Bali, 
healthcare providers are concentrated here. In Denpasar, a city-regency itself surrounded by the 
wealthy Badung regency, I conducted interviews with practitioners at private hospitals practices. 
I travelled outside Denpasar to conduct interviews with the public and with diabetes patients. I 
conducted two interviews with diabetes patients in a village called Kayubihi in the Bangli 
regency. These were two patients of one of the healthcare practitioners I interviewed, Pak Romi, 
a nurse who now runs his own private practice. Thus, I was able to interview stakeholders from 
multiple regencies in Bali, from urban to rural. Each interview was about 40 minutes to an hour. 
 For my interviews, I wrote down sets of 15-20 questions tailored to each stakeholder. I 
had separate questions for healthcare practitioners and for patients. Each set of questions was 
written first in English then translated to Bahasa Indonesia. My procedure for each interview was 
as follows: I first informed my interviewee about the scope of my project and the final paper I 
would produce. I then obtained verbal consent to include the interview in this project, as well as 
consent to record the interview. Next, I began with my set of questions, although the actual 
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conversation would often deviate based on the participants’ answers, such that some questions 
became obsolete and some new follow-up questions emerged. I also took notes, either on my 
computer or in paper. That way, I later had access to what I had been thinking at the time, as well 
as a verbal record to clarify any issues that arose with the language barriers or that I missed in 
my notes. All of my interviews with healthcare practitioners and patients had been scheduled by 
either my advisor or Pak Romi, so each interviewee had been informed of my study and knew 
they were going to be interviewed. 
I went into each interview with a healthcare professional with the same set of about 20 
questions. After explaining the purpose of the interview and obtaining consent, I asked about my 
interviewee’s background in healthcare. Then I would begin asking about the diagnosis of 
diabetic patients, such as the most common reason for seeking medical care, the typical age of 
diagnosis, and the frequency of routine medical check-ups. I would then ask about treatment 
options for diabetics, the typical patients’ adherence to treatment, and the most common 
complications that arise. The final section of the interview focused on how BPJS has affected 
diabetics’ ability to obtain medication, come in for follow-up appointments, and otherwise 
manage their condition. 
 I interviewed four healthcare practitioners, three doctors and one nurse. The first doctor I 
interviewed on November 8, 2018 at Surya Husadha hospital. Dr. Kade Martini has worked at 
this private hospital as a general practitioner for 15 years and is good friends with my advisor Dr. 
Jon, who used to work at the hospital and accompanied me to the interview. She works in the 
emergency room of Surya Husadha and at a BPJS clinic, a Puskesmas, public health center in 
Badung. She spoke in mixed Bahasa Indonesia and English, with Dr. Jon helping fill in the gaps 
for me. 
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I interviewed another doctor at Surya Husadha hospital on November 27, 2018, Dr. 
Wahyu Permana. He has been a general practitioner for two years, and in 2016 started working 
in the executive ward, which frequently deals with tourists. Dr. Wahyu also has a Master’s 
degree in management for hospitals and was well versed in the details of BPJS. This interview 
was conducted largely in English, with Dr. Jon occasionally serving as an intermediary. 
 The last doctor I interviewed on November 30, 2018 at Udayana University in his office, 
Dr. Ketut Suarjana. He has been a general practitioner since 2003. He worked at a hospital from 
2003-2006, but since 2006 he has worked at the private Klinik Pratama Wiratia in Denpasar. 
Most of his patients are BPJS members living in Denpasar, although he sometimes gets patients 
from rural villages that come to the city to confirm their diagnoses. About half his clients are 
actually from Java. Dr. Ketut is a BPJS provider. His practice focuses on primary care and 
preventing noncommunicable diseases. I used the same set of questions with Dr. Ketut as I did 
with the doctors at Surya Husadha. This interview was conducted in largely in English, without 
the aid of Dr. Jon. 
The other healthcare practitioner I interviewed was Pak Romi on November 12, 2018, at 
his private practice called Bali One Care in Denpasar. Pak Romi worked with my advisor as a 
nurse at BIMC hospital for 14 years in the emergency room, dealing with many international 
patients. He started Bali One Care in 2012, a private practice that leases medical equipment and 
the first company in Bali to offer mobile assistance to people with disabilities or other motor 
issues. I used the same set of questions with Pak Romi as I did with the doctors. This interview 
was conducted entirely in English and without the presence of my advisor, as Pak Romi has a 
much better command of medical English than I do of medical Bahasa Indonesia.  
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During our interview, Pak Romi invited me to join his family to his village of Kayubihi 
the following weekend the conduct interviews with some of his patients in the village. I 
accepted, and interviewed two older men from the village on Sunday November 18, 2018. These 
interviewers necessitated help from Pak Romi, as the patients only spoke Balinese or spoke very 
limited Bahasa Indonesia. Thus, these interviews were conducted in a mix of English, Bahasa 
Indonesia, and Balinese, with Pak Romi serving as the intermediary.  
I had a set of interview questions for patients consisting of about 15 questions. After 
explaining my project and obtaining consent, I asked about prior knowledge of diabetes before 
diagnosis and about any family history with noncommunicable diseases. Then, I asked about 
when they received their diagnosis, and namely what symptoms drove them to seek medical care. 
I then asked about their treatment regimen and how their lifestyle had changed since their 
diagnosis, as well as about family involvement in this. Finally, I ended the interview by asking 
about their BPJS status and where they obtained their medication. 
Limitations 
One of my largest limitations in this study was my location. I stayed in Denpasar and the 
Badung regency because of the concentration of healthcare services here, but this also kept me in 
the wealthiest parts of Bali for my interviews with healthcare practitioners. The experience of 
doctors and nurses in Denpasar and Badung might differ greatly from that of their peers in other 
poorer and less urban regencies, where there are less health facilities and resources. 
Likewise, I was only able to interview patients in Kayubihi, a rural village. As described 
above, the situation of diabetics in rural regencies is quite different than that of their counterparts 
in more urban regencies with more money in healthcare. Patients in Denpasar and Badung seems 
more apt to come in for regular check-ups or to seek medical care in general because of the 
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abundance of clinics and hospitals in these regencies. These populations also tend to have more 
awareness about noncommunicable diseases. Although I heard about the experience of patients 
in the city from the healthcare providers I interviewed, I was unable to interview someone 
firsthand about their experience as a diabetic in Denpasar or Badung. 
Another limitation was obviously the language barrier. Although the healthcare 
practitioners I spoke to were mostly fluent in English, occasionally exact translations (especially 
for medical terms) can convey slightly different ideas. For example, in English when I think of a 
medical check-up, I think of regularly scheduled preventative appointments. For many people in 
Bali, a medical check-up usually occurs when someone experiences severe symptoms and then 
schedules an appointment with a professional. My second and larger limitation was in 
interviewing people from the village in Kayubihi. Here, my interviewees spoke little to no 
Bahasa Indonesia, and my strong accent in Bahasa Indonesia made it hard for my interviewees to 
understand my questions. These interviews were conducted entirely with the use of a translator, 
Pak Romi, who doubles as these patients’ healthcare providers. Thus, I was unable to get direct 
answers from the patients, as Pak Romi would also answer with his experience as the primary 
healthcare provider for these patients. 
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Background 
Literature Review 
I prepared for my study by conducting a literature review about type 2 diabetes in Bali 
and in Indonesia, as well as noncommunicable diseases in general and the Indonesian health care 
system. I found a lack of regionally specific data about type 2 diabetes, and the research I found 
was often outdated due to the massive healthcare reform in 2014 and the introduction of BPJS. 
Nevertheless, this literature review allowed me to make several assumptions going into my 
interviews. 
First, there is low public awareness about type 2 diabetes or its symptoms. 70% of 
diabetes cases go undiagnosed and diagnosis happens late in the disease pathway after two or 
more complications have developed (Soewondo, Ferrario, & Tahapary, 2013). Adherence and 
consistency in treatment is generally low, with practitioners citing low public awareness of 
chronic disease (Fountaine, Lembong, Nair, & Süssmuth-Dyckerhoff, 2016). 
Second, Indonesian health habits have generally worsened over the past three or four 
decades as the archipelago transitions economically. Through personal experience, I know that 
the Indonesian diet is composed of a lot of rice and fried foods. I found that Indonesians have 
some of the highest smoking rates in the world especially for young men, which is tied to a 30-
40% higher risk for developing type 2 diabetes (Fountaine, Lembong, Nair, & Süssmuth-
Dyckerhoff, 2016). Indonesians also consume far above the WHO recommended amount of 
sugar-sweetened beverages per week. 24% of children, 41% of adolescents, and 33% of adults 
consume at least one sugar-sweetened beverage a day, associated with a 25% increased risk of 
diabetes in the future (Laksmi et al., 2018). Furthermore, the shift in the labor sector away from 
manual labor has reduced physical activity. About 25% of adults in Indonesia are physically 
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inactive, compared to around 15-16% in other Southeast Asian countries (Fountaine, Lembong, 
Nair, & Süssmuth-Dyckerhoff, 2016). The widespread use of motorbikes to commute to school 
and work has also cut down on walking.  
Finally, I saw the effects of BPJS on the health of Indonesians is still unclear, as the 
program is quite new. Essentially, in response to poor health outcomes in the country, the 
Indonesian government launched a scheme in 2014 called Jaminan Kesehatan Nasional (JKN) to 
achieve universal health coverage by 2019. Before the launch of JKN, Indonesian healthcare was 
fragmented between private insurance for those who could afford it and public programs for 
various groups, such as the very poorest, government employees, etc. The JKN united these 
various schemes under a single provider, BPJS Kesehatan. BPJS is provided free for the very 
poorest, but is available to all Indonesians for purchase in different “classes” by the public. 
These classes vary only in the quality of the facilities (eg: class 1 might get a private room in a 
hospital whereas class 3 might share a room with eight other beds), not in the quality of care 
received or in the coverage (Wiseman et al., 2018). 
In 2018, the monthly fees for classes 1, 2, and 3 were 80,000 Rp, 51,000 Rp, and 25,500 
Rp respectively (Armalia, 2018). BPJS has a large focus on preventative care, and the Puskesmas 
are expected to promote healthy lifestyles for their members (Wiseman et al., 2018). The 
coverage is fairly standard, covering all degenerative and infectious diseases. Yet over one third 
of Indonesians, mostly those working in the informal sector, remain uninsured. Additionally, 
even members of BPJS are still incurring high out-of-pocket fees. In the first year of BPJS, 18% 
of members still made out-of-pocket payments in health facilities, usually from privately 
purchasing medicine (Hidayat et al., 2015). Public health financing remains at just half the 
requirement to achieve universal health coverage (Wiseman et al., 2018). 
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Interviews in Tabanan 
To prepare for my ISP, I conducted a smaller set of interviews in a village in North 
Tabanan while studying and living with a family there for one week. In the village, I conducted a 
group interview with four female 18-year-old students from Institut Hindu Dharma Negeri, as 
well as individual interviews with two village locals, a middle-aged man at a warung (street 
restaurant) and a teenaged girl at her compound. All interviews were conducted with oral consent 
and entirely in Bahasa Indonesia. I had the same set of questions for each interview.  
The first category for primary data was about healthy habits and people’s lifestyles.  Each 
participant drank at least one sugar-sweetened beverage per day, usually sweetened tea in the 
morning, although this number leaned higher for young people. None of the participants smoked, 
although all participants said that most of their male friends did. All but one respondent admitted 
to rarely physically exercising, typically just once a week – the man I interviewed said that he 
got physical activity every morning through farming. When asked how people could improve 
their health, all participants replied that one can live a healthy lifestyle through eating better, 
eating less sugar, drinking more water, and exercising more. 
 I also asked about people’s habits of seeking medical care. This conversation started with 
questions about what people do when they feel sick, what medicines are kept around the house, 
the frequency of visits to healthcare professionals, etc. The responses were fairly uniform. People 
mostly go to the doctor when they can no longer handle the pain on their own. “Check-up” 
mostly referred to any visit to a medical facility, only used for when the patient feels ill. There 
was a consistent protocol for treating an illness. First, one either does nothing or takes traditional 
medicine and waits for the pain to go away. If symptoms persist, one might take one of the 
medications kept around the house. The interviewees provided a standard list: paracetamol, 
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bodrex, hypertensy, and cajuput oil. If symptoms continue to persist and cannot be withstood, 
patients will go to the Puskesmas or to a private nurse or GP, where in severe circumstances they 
may be referred to the hospital. Generally, participants said that they would only go to the balian 
for a medical problem if going to the hospital did not relieve symptoms, although some 
mentioned older generations going to the balian at higher frequencies. 
We then discussed diabetes and other noncommunicable diseases. By far the most well-
recognized non-communicable disease was hypertension. Each interviewee knew this disease 
and had some understanding that eating too much salt is a risk factor. The village people did not 
know diabetes, or kencing manis. However, all of the students knew it by one of those names. 
All students seemed to know that diabetes type 2 is developed by too much sugar in the diet, 
although they also seemed to think it was passed down genetically.  
One of the students had a family history of diabetes. Her father suffers from diabetes, and 
her grandfather has diabetes and hypertension. She told me that both use oral antidiabetic drugs 
2-3 times a day to treat their diabetes, without injections of insulin. Her father goes to the doctor 
about two times a month to keep his diabetes under control. She connected diabetes to both the 
older age of her father and grandfather, and their smoking and drinking habits. 
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Overview of Diabetes in Bali 
Diagnosis 
Depending on the patient’s awareness of diabetes and the accessibility of health services, 
diagnosis might occur at a Puskesmas, a general practitioner (GP) or nurse’s private practice, or 
even at the emergency room (Dr. K. Martini, pc, November 8, 2018). At the first two locations, 
diagnosis most frequently occurs when a patient comes in with neuropathic symptoms, typically 
with a wound that is healing slowly or not at all (Dr. K. Martini, pc, November 8, 2018) (Pak 
Romi, personal communication, November 12, 2018). Many patients also report feeling 
completely drained and tired before they reach this stage (Pak Romi, pc, November 12, 2018). 
Blood tests are standard and affordable, so most diagnosis occurs in one of these two locations. 
In Denpasar, diagnosis often occurs at the Puskesmas because they are so abundant in the city. 
However, for patients in some rural areas, the closest Puskesmas is still inconveniently far. These 
patients will visit a private practice, either a general practitioner or a nurse, who will suggest a 
diagnosis of diabetes. Some of the older patients might try to go to the balian first, and only 
resort to the hospital if symptoms persist (Dr. K. Martini, pc, November 8, 2018). Thus, for the 
bulk of diabetic patients, diagnosis occurs relatively late in the disease pathway, with patients 
waiting for severe complications to develop before seeking medical care (Pak Romi, pc, 
November 12, 2018). 
In Denpasar, where awareness of diabetes tends to be higher than in rural areas, patients 
might discover they have diabetes at a routinely scheduled medical check-up at a Puskesmas or 
at a GP (Dr. K. Suarjana, personal communication, November 30, 2018). BPJS covers a medical 
check-up every six months for individuals over the age of 35 to test blood pressure, blood sugar, 
uric acid content (a high-risk factor for diabetes in Indonesia), and sometimes cholesterol (Dr. 
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W. Permana, pc, November 27, 2018). The situation of late diagnosis seems to be improving 
with the introduction of BPJS, as the program has removed at least the financial barrier (Dr. K. 
Suarjana, pc, November 30, 2018). In Denpasar, it is not uncommon for patients over the age of 
35 with a family history of noncommunicable diseases to come in for proper routine check-ups 
(Dr. W. Permana, pc, November 27, 2018). Additionally, it is mandatory for many hotel workers 
to have a medical check-up once a year including a blood test, so many workers in the tourism 
industry get diagnosed earlier (Dr. K. Martini, pc, November 8, 2018). 
The Ministry of Health is taking steps towards earlier diagnosis in rural areas. In some 
villages, the Puskesmas occasionally holds outreach programs at the Bale Banjar, the Balinese 
equivalent of the town hall. Here, the Puskesmas will educate citizens about their health and the 
importance of preventing noncommunicable diseases, and provide free check-ups including 
blood sugar tests. These meetings occur infrequently, once a year if at all, and not in every 
village. Regardless, some patients will come to Denpasar to confirm their diabetes diagnosis if 
they test for high blood sugar at the Bale Banjar meetings. 
For patients that are diagnosed at the emergency room, they might discover their diabetic 
status completely on accident. A blood test is routine for anyone over 40 years old, so sometimes 
patients come to the emergency room for unrelated reasons and discover that they have diabetes 
on accident (Dr. K. Martini, pc, November 8, 2018). Occasionally patients who have waited for 
severe complications to develop will be sent to the emergency room for kidney failure, and only 
then receive a diagnosis of diabetes. 
Treatment 
 After diagnosis, the patient is typically referred to the Puskesmas or to a GP if they were 
diagnosed elsewhere. There, patients typically are prescribed a dosage of oral antidiabetic drugs, 
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commonly metformin or glibenclamide (Pak Romi, pc, November 12, 2018). The Puskesmas and 
the GP are supposed to be able to handle noncommunicable diseases on their own, but if the 
patient’s condition is too severe, they will be recommended to a specialist at a hospital (Dr. K. 
Suarjana, pc, November 30, 2018). Once the patient is recommended to this level, insulin is 
almost always prescribed. One recent trend in diabetes care is the increasingly frequent use of 
insulin (Pak Romi, pc, November 12, 2018). Providers are prescribing insulin earlier in the 
treatment pathway because outcomes tend to be better the earlier insulin is used, although some 
patients are intimidated because they think insulin use is a sign that their condition is more 
deadly (Dr. K. Martini, pc, November 8, 2018). In any case, patients that accept are usually 
given a mix of insulin and metformin in this situation, as glibenclamide can make the blood 
sugar too low (Dr. W. Permana, pc, November 27, 2018). Once the patient is under control, they 
are referred back to the GP or the Puskesmas to manage their condition. 
BPJS 
For patients with BPJS, there is a list of oral antidiabetic drugs that BPJS will cover in a 
certain quantity per month, including a typical dosage of metformin and glibenclamide. Insulin is 
covered as well. Any patient who needs a different medication or a higher dosage must pay out-
of-pocket to cover the difference (Pak Romi, pc, November 12, 2018). The pharmacy will send 
the medication to the Puskesmas, where the patient can pick it up. The medication is typically 
given for one month at a time (Dr. K. Martini, pc, November 8, 2018) (Dr. K. Suarjana, pc, 
November 30, 2018). 
The Puskesmas will then cooperate with Prolanis, a monthly program to educate patients 
with noncommunicable diseases about lifestyle changes, to manage treatment (Dr. K. Martini, 
pc, November 8, 2018). Patients can also get a small check-up on blood pressure and blood sugar 
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here (Dr. K. Suarjana, pc, November 30, 2018). In Denpasar, Prolanis is quite popular, as about 
70% of pre-diabetic or diabetic individuals over the age of 50 will attend monthly meetings at the 
Puskesmas (Dr. W. Permana, pc, November 27, 2018). The Puskesmas and the GP are quite 
active about follow up with their patients, calling them to remind them to come to Prolanis 
meetings (Dr. K. Suarjana, pc, November 30, 2018). 
Patients under BPJS are supposed to come to the clinic check-up once a month to manage 
their condition. For a diabetic with other diseases such as hypertension, that number might be 
two or three times a month. In Denpasar and Badung, where there are many clinics, a patient 
may come in three times a week for any minor complication (Dr. K. Martini, pc, November 8, 
2018). BPJS providers say that this is because patients feel as though they have already paid for 
BPJS or have had BPJS deducted from their salaries from their employers (Dr. K. Suarjana, pc, 
November 30, 2018). Thus, they want to “get their money’s worth” and will come in frequently. 
Non-BPJS 
 The situation looks quite different for individuals that do not use either remain uncovered 
by BPJS or have BPJS and choose not to use it. For the former, families that are not low-income 
enough to qualify for free BPJS from the government might not be willing to pay for BPJS 
themselves, especially if the public facilities are located far away. For the latter, many 
individuals that are covered by BPJS choose not to use their insurance in certain situations to 
forego the bureaucratic regulations involved (Dr. Jon, personal communication, November 15, 
2018).  
These patients will obtain their medication not from the Puskesmas or from the GP, but 
from a private pharmacy, where it can be purchased in larger doses. Metformin is affordable and 
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can be purchased over the counter, with an average monthly dosage costing about 50,000 Rp 
(Pak Nyoman Kuat, personal communication, November 18, 2018). 
 These patients will go to the clinic or the private nurse for a check-up only when 
complications arise. Outside of Denpasar and Badung, the resistance to seeking medical care is 
much stronger. Even if their blood sugar is not well-managed, the patient will typically only 
come seek care when their condition worsens to the point that they cannot go about their daily 
lives, and even then only at the urging of family (Pak Wayan Karem, personal communication, 
November 18, 2018). They typically have lower adherence to medication as well, as some 
patients will stop taking their medications once they feel back to normal (Dr. K. Suarjana, pc, 
November 30, 2018). 
 As for lifestyle changes, as self-care behaviors are extremely important in the treatment 
of noncommunicable diseases, they vary drastically case by case. When asked about patients’ 
adherence to lifestyle changes, healthcare practitioners had very different answers. Dr. Kade 
Martini reported generally poor adherence to healthier habits, citing her own family as examples. 
Pak Romi reported that he knew just as many patients that poorly adhered to their regimens as he 
did patients that were very strict. Dr. Wahyu Permana, the youngest doctor, said that patients 
were generally very good with changing their diets.  
Outcomes 
 Outcomes are heavily correlated to location, as seen above. Patients in Denpasar and 
Badung tend to have better adherence to medication and are better about follow-up appointments 
with their counterparts in different regencies, so their outcomes tend to be better. Dr. Ketut 
Suarjana reported that most of his patients take their health very seriously, and that he in fact had 
never had a diabetic patient with complications.  
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After the first six months of treatment, many diabetic patients in Denpasar and Badung 
will achieve a HbA1c under 200 mg/dL. The most common complications are neuropathic, with 
patients coming to the clinic frequently for small wounds that are not healing. Hypoglycemia 
(dangerously low blood sugar) is also common, resulting from poor management of blood sugar, 
with Dr. Wahyu Permana estimating that it affects around 20-30% of diabetics in Denpasar (Dr. 
W. Permana, pc, November 27, 2018). Patients for this complication often come to the 
Puskesmas complaining of swollen hands and feet (Dr. W. Permana, pc, November 27, 2018).  
 Patients in other regencies of Bali also experience neuropathic complications, but because 
they generally wait longer to seek medical care and have worse adherence to medication, their 
complications might progress to more severe stages. They may let their neuropathy progress to 
the state of infection or even amputation. In rural areas, hyperglycemia (dangerously high blood 
sugar) is much more common than hypoglycemia. Extreme fatigue and weight loss are common 
(Pak Romi, pc, November 12, 2018). 
 Outcomes tend to worsen the longer a person has type 2 diabetes. Healthcare providers 
report that patients get “bored” of taking their medications when they have been diabetic for five 
or more years (Dr. K. Martini, pc, November 8, 2018), as the average type 2 diabetic in 
Indonesia has to take oral medicine two to three times every day. With insulin injections, this can 
result in as many as seven or eight doses of medication a day. Additionally, in areas where 
awareness of diabetes is lower, patients might stop taking their medicine once their neuropathic 
or hypo/hyperglycemic symptoms go away even if their blood sugar remains over 200 mg/dL 
(Pak Romi, pc, November 12, 2018). Thus, as adherence to medication worsens as time goes on, 
so do health outcomes. Dr. Wahyu Permana estimated that in Denpasar, about 30% of patients 
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will develop kidney disease (Dr. W. Permana, pc, November 27, 2018). Most of these patients 
are those that have had diabetes for over five years. 
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Case Studies from Kayubihi 
Pak Wayan Karem 
 Pak Wayan is a 70-year-old male from Kayubihi who works as a farmer. He was 
diagnosed with diabetes in 2015. Upon experiencing extreme fatigue and frequent urination, at 
the urging of his wife, Pak Wayan allowed his son to take him to a nearby nurse’s private 
practice. The nurse performed a blood test and found a high HbA1c level and informed Pak 
Wayan that he might be diabetic, and recommended that he go to the hospital to have the 
diagnosis confirmed and receive medication. As Pak Wayan did not receive an exact diagnosis, 
he remained concerned about his condition but nevertheless held off on going to the hospital. 
 After three months of extreme fatigue, frequent urination, and weight loss, Pak Wayan’s 
wife urged him to seek care. He went to another nurse for a second opinion, who agreed that he 
was likely diabetic. At this point, Pak Wayan called Pak Romi, who frequently serves as a 
caretaker for the people in his village for various ailments. Pak Wayan had no experience with 
kencing manis prior to his diagnosis and reported no family history of the disease. In fact, he 
reported feelings of embarrassment after his diagnosis because he did not know anyone else with 
the disease. As Pak Wayan had no previous experience with diabetes, Pak Romi explained the 
condition to him and provided him with privately purchased metformin. Pak Wayan was 
diagnosed with 500 mg of metformin to take twice a day. After one month, as his blood sugar 
remained quite high, Pak Romi increased this to three times a day in addition to two tablets of 
glibenclamide a day. Pak Wayan also uses traditional herbal medicine to treat his fatigue 
symptoms. 
 Pak Wayan has BPJS, although he was not sure what class he had purchased because he 
rarely uses it. Metformin and glibenclamide are relatively cheap, and BPJS is a hassle to use 
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because it requires lots of referrals and bureaucratic hoops to jump through. Thus, Pak Wayan’s 
family pays out-of-pocket to avoid the hassle and obtain medication quickly. His medication 
costs about 50,000 Rp a month. 
 Since his diagnosis, with the help of Pak Romi and his family, Pak Wayan’s condition 
has improved considerably. His wife is very strict about his adherence to medication and lifestyle 
changes, such that Pak Wayan takes his medicine regularly. He has also made drastic changes to 
his diet, eating very little rice and cutting down on sugar while increasing his vegetable intake. 
After about one month on the increased medication dosage, Pak Wayan reported feeling better. 
He was able to start working again soon afterwards, and has felt largely back to normal since 
then. He normally does routine check-ups every few months. His last appointment was in 
August, when his blood sugar was perfectly healthy around 200 mg/dL. 
Pak Nyoman Kuat 
 Pak Nyoman is a 63-year-old male from Kayubihi who works as a farmer. He was 
diagnosed with diabetes in 2010. He experienced extreme fatigue, thirst, frequent urination, and 
weight loss (all telltale signs of type 2 diabetes). Like Pak Wayan, he first went to see a private 
nurse, who did a blood test. She found that his HbA1c was 450 mg/dL and told him he was 
diabetic, and that he needed to go to the hospital. Pak Nyoman, who had no prior exposure to 
kencing manis, further resisted going to the hospital for two more months, after which point his 
son called Pak Romi for advice. Pak Romi came back to the village and took Pak Nyoman to a 
hospital in Denpasar to see an internist to confirm his diagnosis and receive medication. 
 Pak Nyoman was prescribed 500 mg of metformin, twice a day, and two tablets of 
glibenclamide a day. His initial prescription lasted for two weeks, and he renewed his 
prescription three more times, so he took his medication consistently for eight weeks. After eight 
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weeks, Pak Nyoman’s blood sugar was under control. He regained his energy and was able to get 
back to work. Because he felt normal again, Pak Nyoman thought his diabetes was cured and that 
he no longer needed to take medication. He stopped renewing his prescriptions for metformin 
and glibenclamide.  
 Pak Nyoman remained unmedicated until 2017. During this time, he would occasionally 
experience neuropathic symptoms such as small wounds healing slowly, and would go to a 
private nurse to treat the wounds. But he did not start taking medication again until 2017, when 
he again started to experience extreme fatigue. At the urging of his family, he began taking the 
same dosage of metformin again. His energy level again improved, although he continued to 
experience small infections he would treat on a case-by-case basis. 
 In April 2018, Pak Nyoman got a sizable cut on his third toe while farming. He taped it 
tightly and covered it with plastic, closing off circulation, because he was scared that his family 
would see it and pressure him to go to the hospital. After five days, his son noticed that the 
wound was infected and called Pak Romi, who told him to take Pak Nyoman to the doctor. Pak 
Nyoman resisted for fear that the doctor would amputate the toe. He continued to wait until the 
toe turned black and gangrenous, even when Pak Romi urged him to go to the hospital to prevent 
the infection from spreading. Finally, Pak Nyoman said he would go to the hospital if Pak Romi 
came back to the village to inspect his toe in person and still ordered him to go. 
 Pak Romi came back to the village and took Pak Nyoman to a hospital, where the doctors 
had to amputate his two middle toes to stop the infection from spreading to his blood. Here, his 
prescription was changed. Glibenclamide was stopped, and Pak Nyoman was prescribed 
injections of insulin four times a day in addition to his normal dose of metformin. He also takes a 
different, longer lasting form of insulin called Lantus to control his blood sugar at night. His 
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prescription changed again slightly in November 2018, to a slightly higher dose of metformin. 
He now goes to the hospital every month to check on his blood sugar and to see if his insulin 
prescription needs to be adjusted. 
 Pak Nyoman has class 3 BPJS and uses it to pay for his medication. BPJS covers all of 
his insulin and other medications, so he incurs no out-of-pocket charges. He usually goes to 
Bangli General Hospital, the public hospital in his regency, where there is an apothecary where 
he can pick up his medication. 
 Since April 2017 when his prescription first changed, Pak Nyoman’s health has 
improved. His energy level has improved, and he has been working as normal. Like Pak Wayan, 
Pak Nyoman also made changes to his diet and lifestyle. He eats little rice and no sugar at all, 
and very little meat. The morning of our interview, his HbA1c level was an impressive 126 
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Analysis 
Resistance to Seeking Medical Care 
 Balinese generally wait for severe complications to develop before seeking medical help, 
and often only at the pressure of family members. The situation is much better in Denpasar and 
Badung, where there are more health facilities and greater awareness of noncommunicable 
diseases, but in other regencies the public resists visits to healthcare professionals.  
There are complex factors beyond this resistance, but essentially many Balinese actively 
avoid seeking medical care because they do not want to know if they have health issues. For 
some, this is a financial issue. If they know they have a disease, they will have to spend money to 
take care of it, and they would rather remain ignorant of their status until it seriously impedes 
their daily life (Pak Romi, pc, November 12, 2018). 
But more widespread is the mindset that knowing they have a disease will somehow 
make the disease worse, and that they are happier not knowing. Both Dr. Kade Martini and Pak 
Romi cited this mindset as the single largest issue with treating diabetic patients, because 
patients are so scared to find out that something is wrong with their bodies that they will avoid 
getting primary care even if they have BPJS and the appointment is free of charge (Dr. K. 
Martini, pc, November 8, 2018). Although blood tests are relatively cheap (about 50,000 Rp in 
Denpasar) and required for patients over 40, patients will still refuse them out of this fear (Dr. K. 
Martini, pc, November 8, 2018). They would rather not know they have an illness and live in 
peace than expend the stress and mental energy to properly manage their condition. This was 
seen in the case of Pak Romi’s patients from Kayubihi, who both received diagnoses from 
private nurses and still refused to go to the doctor to get proper confirmation until Pak Romi 
came to the village in person and took them. 
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Thus, lack of awareness is not the only factor impeding diagnosis, and certainly not the 
largest. The mindset of many Balinese that “ignorance is bliss” when it comes to their health 
status is a major contributor. 
Misunderstandings about Chronic Disease 
There is widespread misunderstanding about diabetes as a chronic disease. Many 
Balinese think of being “sick” as synonymous with “having symptoms,” such as extreme fatigue 
or frequent urination. The thought process is that the disease is cured when the symptoms 
disappear. For many common illnesses in Bali, this is true: a patient takes medication for their 
fever, and they are cured when their temperature is back to normal. But for diabetes, even if a 
patient is perfectly able to go about their daily lives, they are considered diabetic as long as their 
blood sugar is above a certain level. Even well-managed diabetics need to continue taking 
medication and coming in for follow-up appointments with their healthcare professionals in 
order to maintain their health. The mindset that having no symptoms means the disease has been 
cured is problematic for chronic diseases. 
 This is one reason why many Balinese do not do regular check-ups, as they typically wait 
for symptoms to develop before seeking care, but it also has a great impact on adherence to 
medication. For some patients, once symptoms are relieved, they consider themselves to no 
longer be sick even if their HbA1c level is far above 200 mg/dL (Pak Romi, pc, November 12, 
2018). Some of this may be psychological, as patients want to believe they are in good health. 
They do not want to believe that their illness is chronic and will likely affect them for the rest of 
their lives. In the case of Pak Nyoman, he fully stopped taking his medication for seven years 
when his symptoms stopped because he did not understand diabetes as a chronic disease 
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requiring long term treatment. He only went to the hospital to care for small infections, not for 
consistent treatment. 
 In the long term, this mentality is harmful as it decreases adherence to medication, which 
can lead to negative health outcomes. The bulk of diabetics that experience kidney failure are 
patients that have had diabetes for over five years, and are “bored” of taking their medication 
when their symptoms have already disappeared and they feel perfectly normal (Dr. W. Permana, 
pc, November 27, 2018). 
Regional Differences 
 An overarching theme throughout my project was the difference in behavior between 
different regencies. The health behaviors of patients in the richer provinces of Denpasar and 
Badung were systematically more positive than in other provinces. Denpasar and Badung are 
richer provinces with more resources in their healthcare facilities, increasing the accessibility of 
public healthcare. Additionally, the Puskesmas and the GP are expected to strictly adhere to the 
principles of BPJS in these regencies due to the money involved, and to focus on prevention and 
awareness (Dr. K. Martini, pc, November 8, 2018). Thus, the people living here have greater 
awareness of noncommunicable diseases. They may also have family members working in the 
health sector that alert them to health issues. If they are hotel workers, many companies mandate 
that they have an annual medical check-up. Other employers purchase BPJS for their employees, 
sometimes deducting it out of their salary, so that patients feel they have to get check-ups so as 
to not waste their money (Dr. K. Suarjana, pc, November 30, 2018). Additionally, most people 
here are insured by BPJS and use it to obtain medication free-of-charge from the Puskesmas. 
Diabetes here is mostly handled at the Puskesmas and GP level. 
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 Two of the healthcare providers I interviewed, Dr. Wahyu Permana and Dr. Ketut 
Suarjana, had mostly positive things to say about diabetes. They reported that their patients 
usually discovered their diagnosis through a regular check-up before complications developed, 
and that most of them were good about taking their medication and following up with 
appointments, especially those who had a family history of the disease. Dr. Wahyu Permana 
reported that complications like hypoglycemia and neuropathy are common enough but not 
usually severe, and that patients frequently come to the clinic for check-ups anyway. Dr. Ketut 
Suarjana, who works in a primary care facility that focuses on early diagnosis and prevention, 
said he had never had to treat a diabetes patient with a complication. Both seemed to attribute 
these positive changes to the introduction of BPJS, as the removal of the financial barrier to 
service has made more and more people come in for medical care.  
These accounts differed drastically from the other healthcare providers I interviewed, Dr. 
Kade Martini and Pak Romi, who have more patients that live in other regencies and stated that 
diagnosis occurs more often at late stages. People in other regencies are less likely to seek 
medical care and adhere to treatment (Dr. K. Suarjana, pc, November 30, 2018). They also tend 
to have lower utilization of BPJS services. Due to lower accessibility of health facilities, most 
patients go to private nurse practices until their complications grow serious. Many will also only 
discover that they have blood sugar when the Puskesmas holds a health education meeting and 
free check-up at the Bale Banjar, and only then come to a hospital to confirm their diagnosis (Dr. 
K. Suarjana, pc, November 30, 2018). People that do not utilize BPJS are also less likely to 
adhere to medication and to follow-up with their doctors. 
This makes the analysis of diabetes in Bali quite complex, as statements that hold true for 
patients in rural areas might be completely contradictory to the reality of patients in Denpasar 
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(Pak Romi, pc, November 12, 2018). The issues described above are more applicable to the 
former areas than the latter. 
BPJS 
Focus on Primary Care 
 Every healthcare practitioner I interviewed mentioned the massive deficit of BPJS. The 
program is deeply in debt, much of which can be attributed to the late diagnosis of chronic 
diseases such as diabetes. When the diagnosis occurs early in the disease pathway, BPJS need 
only pay for the patient’s medication, which is relatively cheap. When diagnosis occurs after 
complications develop, especially serious complications like kidney failure, BPJS has to cover 
treatment for these complications as well as ensuing regular medication. It is far cheaper to 
prevent noncommunicable diseases than to treat them. Thus, in regencies where it is financially 
feasible, BPJS has a large focus on prevention and early identification of noncommunicable 
diseases (Dr. K. Suarjana, pc, November 30, 2018). In Badung, BPJS even covers home visits 
(Dr. K. Martini, pc, November 8, 2018). The program covers 6-monthly check-ups for all 
members, including a blood test (Dr. W. Permana, pc, November 27, 2018). 
Resistance to Use 
 Through both my interviews and informal interactions, I found that many people that are 
covered by BPJS resist using their public health insurance. Most people I met in informal  
situations had BPJS, but reported that they rarely used it, preferring to pay privately to avoid the 
many bureaucratic regulations of the program (Dr. Jon, personal communication, November 15, 
2018). For example, BPJS has a strict system of referrals wherein a diabetic must first go to a GP 
or the Puskesmas to get referred to a specialist doctor, rather than going directly to the specialist 
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themselves. It is not uncommon for patients to just pay out-of-pocket to avoid jumping through 
these hoops. 
Confusion over Usage 
 BPJS is a very new program, and is constantly undergoing revisions to its procedures. As 
such, many of the healthcare providers I met expressed some confusion over the program. The 
regulations, particularly in regards to the complex system of referrals, are revised frequently and 
often without alerting the facilities or the public (Dr. Jon, pc, November 15, 2018). This leads to 
wasted time and frustration for both the patient and the provider, and wasted money for the 
program. This inefficiency goes beyond complications with communicable diseases and seems to 
be an overarching theme in BPJS, necessitating better communication between the program, the 
practitioner, and the patient. 
Trends in Diabetes Diagnosis and Management 
Increasingly Earlier Diagnosis 
 While the problem of late-stage diagnosis remains serious, the healthcare professionals I 
interviewed seemed hopeful that the situation has taken a positive turn in recent years. With the 
introduction of smartphones, awareness about noncommunicable diseases has increased because 
even patients fearful of a diagnosis can simply look up their symptoms on the internet (Dr. K. 
Suarjana, pc, November 30, 2018). The focus of BPJS on primary care and outreach to Bale 
Banjars from the Puskesmas has also led to diagnosis earlier in the disease pathway. Healthcare 
providers seemed confident that the mindset of Balinese who resist medical care can and will 
change as health education grows more widespread. In fact, that change has clearly already 
started in Denpasar, where practitioners reported that many people come in for regular check-
ups. 
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Increasing Adherence to Medication and Lifestyle Changes 
 In the same vein, good adherence to medication and lifestyle changes seems to be 
increasing in Bali as awareness and health education increases. The influence of BPJS in 
Denpasar and Badung is apparent. Prolanis in particular is surprisingly popular, with an 
estimated 70% of BPJS members that qualify for the program attending the monthly meetings 
(Dr. W. Permana, pc, November 27, 2018). Patients with BPJS are better about coming in for 
follow-up appointments, as they want to get their money’s worth from the program. It also helps 
that the Puskesmas in Denpasar and Badung are quite proactive about calling patients and 
reminding them to follow up. As awareness of the nature of chronic disease spreads, practitioners 
seem to be thinking positively about treatment outcomes in the future. 
Increasing Insulin 
 The most common medication for a type 2 diabetic is oral antidiabetic drugs, most 
commonly metformin at a dosage of 500 milligrams twice a day. However, doctors report that 
insulin is becoming increasingly common when patients are referred to the hospital (Dr. K. 
Martini, pc, November 8, 2018). If the GP or the Puskesmas is unable to handle the patients’ 
complications, they will refer the patient to see the hospital to see an internist. More commonly 
than not, these days the patient will be prescribed insulin in addition to whatever oral antidiabetic 
drug they are using (Dr. W. Permana, pc, November 27, 2018). Doctors say this is done because 
insulin is a more effective treatment and health outcomes tend to be better the earlier a patient 
starts on insulin, although insulin is more expensive. 
  
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 36 
Conclusion 
As expected, many of the assumptions I had made from my literature review were 
challenged by my primary data. After first four interviews, which were with Dr. Kade Martini, 
Pak Romi, and the two patients Pak Wayan and Pak Nyoman, combined with the primary data I 
gathered in Tabanan before the start of my independent study, I thought I had confirmed some of 
those assumptions. In these interviews, I learned that diagnosis occurred late in the disease 
pathway, that awareness of noncommunicable diseases among patients was generally low, and 
that adherence to treatment was difficult to achieve. However, every healthcare providers’ 
perspective is different, and my last two interviews with Dr. Wahyu Permana and Dr. Ketut 
Suarjana provided completely contrasting viewpoints. They found diagnosis to happen early in 
the disease pathway, adherence to medication and lifestyle changes to be generally good, and 
complications to be rare. This can partly be attributed to the regional differences in my 
interviews, but these contradictions also reflect the rapidly changing state of healthcare in Bali. 
Awareness and education of health issues are rising, with the ease of access to the internet and 
the introduction of BPJS removing barriers to healthcare. 
Mindsets can change. In the words of Dr. Kade Martini, “semua bisa berubah” – anything 
can change. Even ten or fifteen years ago, she says, the Balinese did not like to travel outside 
their villages. Now people from every regency live and work in Denpasar and travel to other 
provinces of Indonesia, or even other parts of the world. The mindsets around resisting medical 
care and adherence to medication can and will change as awareness around noncommunicable 
diseases increases. This state of change is reflected in my paper. Beyond regional differences, the 
conflicting reports of healthcare professionals of the state of diabetes in Bali reflect the changes 
that have already begun. 
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Bali’s health system is in a state of transition. Even as the prevalence of 
noncommunicable diseases is rising quickly and healthcare-resistant mindsets persist, the island 
is taking massive steps in conjunction with BPJS towards prevention and earlier diagnosis of the 
disease. These steps are highly ambitious and not without confusion, as practitioners and patients 
alike are sometimes blindsided by the constant revising of BPJS, but they nevertheless will be 
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Suggestions for Further Research 
Regionally Specific Data 
 One challenge in my study has been the lack of statistics specific to Bali, not just 
Indonesians. Indonesia is a country composed of over 17,000 islands, incredibly diverse in its 
languages, ethnicities, geographies, religions, etc. Yet BPJS is a single state provider with a 
uniform set of regulations for every province. Further study of noncommunicable disease in 
Indonesia should make an effort to differentiate between regions. If possible, studies in Bali 
should break down data by regency as well, as outcomes seem to vary drastically. 
Health Equity 
 In the same vein, more research is needed in health equity in Indonesia and Bali with the 
introduction of BPJS. Health outcomes are clearly improving for some populations more than 
others, as some regencies have more money to spend on BPJS facilities. Work should be done on 
how BPJS can increase the health equity of its programming.  
Other Noncommunicable Diseases 
 Diabetes is not the only noncommunicable disease on the rise in Indonesia. Hypertension 
came up frequently during my interviews. Patients with diabetes are more likely to suffer from 
other noncommunicable diseases such as hypertension, cardiovascular disease, and respiratory 
disease. In fact, some healthcare providers expressed concern that many of their patients are 
suffering from two noncommunicable diseases simultaneously (Dr. W. Permana, pc, November 
27, 2018) (Dr. K. Suarjana, pc, November 30, 2018). More research is needed on the joint 
treatment of diabetes and hypertension, as well as treatment for noncommunicable diseases in 
general. 
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Balian in Present-Day Healthcare 
 One topic left unclear by my study was the importance of the balian, Balinese Hindu 
spiritual healers, in present-day healthcare. My interviews in Tabanan with younger students 
from Denpasar yielded contradictory results, with some students saying that they only go to the 
balian for spiritual issues while other students claimed to visit for medical issues as well. The 
latter seemed to think of the balian as a last resort for medical issues, when a trip to the hospital 
does not relieve symptoms. Dr. Kade Martini and Pak Romi seemed to view the balian as a 
preferred method of seeking medical care for older people in the village, while Dr. Wahyu 
Permana claimed that Balinese patients will typically seek a mixture of care from the balian and 
from healthcare facilities.  
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Glossary 
Badan Penyelenggara Jaminan Sosial (BPJS): The Social Insurance Administration 
Organization, one of the largest single state providers in the world. As of 2018, 195 million 
Indonesians are covered. BPJS covers all degenerative and infectious diseases. It is offered free 
of charge to low-income families, and is offered in three classes for purchase to all Indonesians. 
Employers can also purchase BPJS in any class for their employees. These classes differ only in 
the facilities, not in coverage or quality of care (Wiseman et al., 2018). 
Glycated hemoglobin test (HbA1c): One of the most common tests to diagnose diabetes, this test 
is used to determine the average blood sugar of a patient over the past two to three months. The 
target HbA1c level for diabetic individuals is usually under 7.0 millimoles per liter, or under 200 
milligrams per deciliter (mg/dL) (Dansinger, 2018). 
Kencing manis: Literally meaning “sweet urine,” this is the colloquial term for type 2 diabetes.  
Many people in rural areas do not know the word “diabetes” (even diabetics themselves) but are 
familiar with kencing manis. 
Jaminan Kesehatan Nasional (JKN): Indonesia’s healthcare scheme launched in 2014 to achieve 
universal health coverage by 2019. This scheme combined all previous government schemes 
under one national provider, BPJS (Wiseman et al., 2018). 
Metformin and glibenclamide: Two of the most common oral antidiabetic drugs prescribed for 
type 2 diabetes. BPJS provides these medications free of charge for pick-up at the Puskesmas for 
a month at a time (Dr. K. Martini, pc, November 8, 2018). 
Neuropathy: One of the most common symptoms of poorly managed or unmanaged diabetes. It 
refers to nerve damage that occurs as a result of consistently high blood sugar, causing affected 
areas such as the hands and feet to lose sensation.  
SILENT KILLERS: DIABETES AND THE ACTIVE IGNORANCE OF NONCOMMUNICABLE DISEASE IN BALI Lambert 41 
Prolanis: A program under BPJS for individuals identified as at-risk for diabetes and other 
noncommunicable diseases. It is a monthly program held at the Puskesmas, focusing on 
education of healthy lifestyles such as proper exercise and diet (Dr. K. Martini, personal 
communication, November 8, 2018). 
Puskesmas: Public clinics. One Puskesmas serves every 3000 people (Dr. W. Permana, personal 
communication (pc), November 27, 2018). Most care for diabetes, hypertension, and other 
noncommunicable diseases occurs here. 
Type 2 diabetes mellitus: A metabolic disorder that refers to the inability or impaired ability of 
cells to respond properly to insulin or to make insulin, characterized by dangerously high blood 
sugar. Compared to type 1 diabetes mellitus, in which afflicted individuals are born without the 
ability to secrete sufficient insulin, type 2 diabetes mellitus is typically adult-onset and tends to 
affect older individuals. 
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